PD-L1 Expression and Outcome in Patients with Metastatic Non-Small Cell Lung Cancer and EGFR Mutations Receiving EGFR-TKI as Frontline Treatment

PD-L1 Expression and Outcome in Patients with Metastatic Non-Small Cell Lung Cancer and EGFR Mutations Receiving EGFR-TKI as Frontline Treatment

Cheng-Yu Chang,1,* Yi-Chun Lai,2,3,* Yu-Feng Wei,4,5,* Chung-Yu Chen,6,7,* Shih-Chieh Chang2,8 1Division of Chest Medicine, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan; 2Division of Chest Medicine, Department of Internal Medicine, National Yang Ming Chiao...

Full description

Bibliographic Details
Main Authors: Chang CY, Lai YC, Wei YF, Chen CY, Chang SC
Format: Article
Language:English
Published: Dove Medical Press 2021-03-01
Series:OncoTargets and Therapy
Subjects:
programmed death-ligand 1
epidermal growth factor receptor mutation
epidermal growth factor receptor tyrosine kinase inhibitors
Online Access:https://www.dovepress.com/pd-l1-expression-and-outcome-in-patients-with-metastatic-non-small-cel-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/pd-l1-expression-and-outcome-in-patients-with-metastatic-non-small-cel-peer-reviewed-article-OTT

Similar Items